Global HER-2 Targeted Drugs for Breast Cancer Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
SKU ID : QYR-18541656 | Publishing Date : 14-Jun-2021 | No. of pages : 118
Detailed TOC of Global HER-2 Targeted Drugs for Breast Cancer Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
1 Market Overview of HER-2 Targeted Drugs for Breast Cancer1.1 HER-2 Targeted Drugs for Breast Cancer Market Overview
1.1.1 HER-2 Targeted Drugs for Breast Cancer Product Scope
1.1.2 HER-2 Targeted Drugs for Breast Cancer Market Status and Outlook
1.2 Global HER-2 Targeted Drugs for Breast Cancer Market Size Overview by Region 2016 VS 2021VS 2027
1.3 Global HER-2 Targeted Drugs for Breast Cancer Market Size by Region (2016-2027)
1.4 Global HER-2 Targeted Drugs for Breast Cancer Historic Market Size by Region (2016-2021)
1.5 Global HER-2 Targeted Drugs for Breast Cancer Market Size Forecast by Region (2022-2027)
1.6 Key Regions, HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027)
1.6.1 North America HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027)
1.6.2 Europe HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027)
1.6.3 Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027)
1.6.4 Latin America HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027)
1.6.5 Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027)
2 HER-2 Targeted Drugs for Breast Cancer Market Overview by Type
2.1 Global HER-2 Targeted Drugs for Breast Cancer Market Size by Type: 2016 VS 2021 VS 2027
2.2 Global HER-2 Targeted Drugs for Breast Cancer Historic Market Size by Type (2016-2021)
2.3 Global HER-2 Targeted Drugs for Breast Cancer Forecasted Market Size by Type (2022-2027)
2.4 Trastuzumab
2.5 Pertuzumab
2.6 Lapatinib
2.7 Neratinib
2.8 Trastuzumab Emtansine
2.9 Pyrotinib
2.10 Other
3 HER-2 Targeted Drugs for Breast Cancer Market Overview by Application
3.1 Global HER-2 Targeted Drugs for Breast Cancer Market Size by Application: 2016 VS 2021 VS 2027
3.2 Global HER-2 Targeted Drugs for Breast Cancer Historic Market Size by Application (2016-2021)
3.3 Global HER-2 Targeted Drugs for Breast Cancer Forecasted Market Size by Application (2022-2027)
3.4 Hospital
3.5 Clinic
3.6 Drug Center
3.7 Other
4 HER-2 Targeted Drugs for Breast Cancer Competition Analysis by Players
4.1 Global HER-2 Targeted Drugs for Breast Cancer Market Size by Players (2016-2021)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in HER-2 Targeted Drugs for Breast Cancer as of 2020)
4.3 Date of Key Players Enter into HER-2 Targeted Drugs for Breast Cancer Market
4.4 Global Top Players HER-2 Targeted Drugs for Breast Cancer Headquarters and Area Served
4.5 Key Players HER-2 Targeted Drugs for Breast Cancer Product Solution and Service
4.6 Competitive Status
4.6.1 HER-2 Targeted Drugs for Breast Cancer Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Roche
5.1.1 Roche Profile
5.1.2 Roche Main Business
5.1.3 Roche HER-2 Targeted Drugs for Breast Cancer Products, Services and Solutions
5.1.4 Roche HER-2 Targeted Drugs for Breast Cancer Revenue (US$ Million) & (2016-2021)
5.1.5 Roche Recent Developments
5.2 Chugai Pharmaceutical
5.2.1 Chugai Pharmaceutical Profile
5.2.2 Chugai Pharmaceutical Main Business
5.2.3 Chugai Pharmaceutical HER-2 Targeted Drugs for Breast Cancer Products, Services and Solutions
5.2.4 Chugai Pharmaceutical HER-2 Targeted Drugs for Breast Cancer Revenue (US$ Million) & (2016-2021)
5.2.5 Chugai Pharmaceutical Recent Developments
5.3 GlaxoSmithKline
5.5.1 GlaxoSmithKline Profile
5.3.2 GlaxoSmithKline Main Business
5.3.3 GlaxoSmithKline HER-2 Targeted Drugs for Breast Cancer Products, Services and Solutions
5.3.4 GlaxoSmithKline HER-2 Targeted Drugs for Breast Cancer Revenue (US$ Million) & (2016-2021)
5.3.5 Novartis Recent Developments
5.4 Novartis
5.4.1 Novartis Profile
5.4.2 Novartis Main Business
5.4.3 Novartis HER-2 Targeted Drugs for Breast Cancer Products, Services and Solutions
5.4.4 Novartis HER-2 Targeted Drugs for Breast Cancer Revenue (US$ Million) & (2016-2021)
5.4.5 Novartis Recent Developments
5.5 Pfizer
5.5.1 Pfizer Profile
5.5.2 Pfizer Main Business
5.5.3 Pfizer HER-2 Targeted Drugs for Breast Cancer Products, Services and Solutions
5.5.4 Pfizer HER-2 Targeted Drugs for Breast Cancer Revenue (US$ Million) & (2016-2021)
5.5.5 Pfizer Recent Developments
5.6 CANbridge
5.6.1 CANbridge Profile
5.6.2 CANbridge Main Business
5.6.3 CANbridge HER-2 Targeted Drugs for Breast Cancer Products, Services and Solutions
5.6.4 CANbridge HER-2 Targeted Drugs for Breast Cancer Revenue (US$ Million) & (2016-2021)
5.6.5 CANbridge Recent Developments
5.7 Puma Biotechnology
5.7.1 Puma Biotechnology Profile
5.7.2 Puma Biotechnology Main Business
5.7.3 Puma Biotechnology HER-2 Targeted Drugs for Breast Cancer Products, Services and Solutions
5.7.4 Puma Biotechnology HER-2 Targeted Drugs for Breast Cancer Revenue (US$ Million) & (2016-2021)
5.7.5 Puma Biotechnology Recent Developments
5.8 Hengrui Medicine
5.8.1 Hengrui Medicine Profile
5.8.2 Hengrui Medicine Main Business
5.8.3 Hengrui Medicine HER-2 Targeted Drugs for Breast Cancer Products, Services and Solutions
5.8.4 Hengrui Medicine HER-2 Targeted Drugs for Breast Cancer Revenue (US$ Million) & (2016-2021)
5.8.5 Hengrui Medicine Recent Developments
5.9 Beacon Pharmaceuticals Limited
5.9.1 Beacon Pharmaceuticals Limited Profile
5.9.2 Beacon Pharmaceuticals Limited Main Business
5.9.3 Beacon Pharmaceuticals Limited HER-2 Targeted Drugs for Breast Cancer Products, Services and Solutions
5.9.4 Beacon Pharmaceuticals Limited HER-2 Targeted Drugs for Breast Cancer Revenue (US$ Million) & (2016-2021)
5.9.5 Beacon Pharmaceuticals Limited Recent Developments
5.10 Hetero Drugs
5.10.1 Hetero Drugs Profile
5.10.2 Hetero Drugs Main Business
5.10.3 Hetero Drugs HER-2 Targeted Drugs for Breast Cancer Products, Services and Solutions
5.10.4 Hetero Drugs HER-2 Targeted Drugs for Breast Cancer Revenue (US$ Million) & (2016-2021)
5.10.5 Hetero Drugs Recent Developments
6 North America
6.1 North America HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2016-2027)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2016-2027)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size by Region (2016-2027)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2016-2027)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2016-2027)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 HER-2 Targeted Drugs for Breast Cancer Market Dynamics
11.1 HER-2 Targeted Drugs for Breast Cancer Industry Trends
11.2 HER-2 Targeted Drugs for Breast Cancer Market Drivers
11.3 HER-2 Targeted Drugs for Breast Cancer Market Challenges
11.4 HER-2 Targeted Drugs for Breast Cancer Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Figures, Tables and Charts Available in Global HER-2 Targeted Drugs for Breast Cancer Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
List of TablesTable 1. Global Market HER-2 Targeted Drugs for Breast Cancer Market Size (US$ Million) Comparison by Region 2016 VS 2021 VS 2027
Table 2. Global HER-2 Targeted Drugs for Breast Cancer Market Size by Region (2016-2021) & (US$ Million)
Table 3. Global HER-2 Targeted Drugs for Breast Cancer Market Size Share by Region (2016-2021)
Table 4. Global HER-2 Targeted Drugs for Breast Cancer Forecasted Market Size by Region (2022-2027) & (US$ Million)
Table 5. Global HER-2 Targeted Drugs for Breast Cancer Forecasted Market Size Share by Region (2022-2027)
Table 6. Global HER-2 Targeted Drugs for Breast Cancer Market Size (US$ Million) by Type: 2016 VS 2021 VS 2027
Table 7. Global HER-2 Targeted Drugs for Breast Cancer Market Size by Type (2016-2021) & (US$ Million)
Table 8. Global HER-2 Targeted Drugs for Breast Cancer Revenue Market Share by Type (2016-2021)
Table 9. Global HER-2 Targeted Drugs for Breast Cancer Forecasted Market Size by Type (2022-2027) & (US$ Million)
Table 10. Global HER-2 Targeted Drugs for Breast Cancer Revenue Market Share by Type (2022-2027)
Table 11. Global HER-2 Targeted Drugs for Breast Cancer Market Size (US$ Million) by Application: 2016 VS 2021 VS 2027
Table 12. Global HER-2 Targeted Drugs for Breast Cancer Market Size by Application (2016-2021) & (US$ Million)
Table 13. Global HER-2 Targeted Drugs for Breast Cancer Revenue Market Share by Application (2016-2021)
Table 14. Global HER-2 Targeted Drugs for Breast Cancer Forecasted Market Size by Application (2022-2027) & (US$ Million)
Table 15. Global HER-2 Targeted Drugs for Breast Cancer Revenue Market Share by Application (2022-2027)
Table 16. Global HER-2 Targeted Drugs for Breast Cancer Revenue (US$ Million) by Players (2016-2021)
Table 17. Global HER-2 Targeted Drugs for Breast Cancer Revenue Market Share by Players (2016-2021)
Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in HER-2 Targeted Drugs for Breast Cancer as of 2020)
Table 19. Date of Key Manufacturers Enter into HER-2 Targeted Drugs for Breast Cancer Market
Table 20. Global HER-2 Targeted Drugs for Breast Cancer Top Players Headquarters and Area Served
Table 21. HER-2 Targeted Drugs for Breast Cancer Product Solution and Service
Table 22. Global HER-2 Targeted Drugs for Breast Cancer Players Market Concentration Ratio (CR5 and HHI)
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Roche Basic Information List
Table 25. Roche Description and Business Overview
Table 26. Roche HER-2 Targeted Drugs for Breast Cancer Products, Services and Solutions
Table 27. Revenue (US$ Million) in HER-2 Targeted Drugs for Breast Cancer Business of Roche (2016-2021)
Table 28. Roche Recent Developments
Table 29. Chugai Pharmaceutical Basic Information List
Table 30. Chugai Pharmaceutical Description and Business Overview
Table 31. Chugai Pharmaceutical HER-2 Targeted Drugs for Breast Cancer Products, Services and Solutions
Table 32. Revenue (US$ Million) in HER-2 Targeted Drugs for Breast Cancer Business of Chugai Pharmaceutical (2016-2021)
Table 33. Chugai Pharmaceutical Recent Developments
Table 34. GlaxoSmithKline Basic Information List
Table 35. GlaxoSmithKline Description and Business Overview
Table 36. GlaxoSmithKline HER-2 Targeted Drugs for Breast Cancer Products, Services and Solutions
Table 37. Revenue (US$ Million) in HER-2 Targeted Drugs for Breast Cancer Business of GlaxoSmithKline (2016-2021)
Table 38. GlaxoSmithKline Recent Developments
Table 39. Novartis Basic Information List
Table 40. Novartis Description and Business Overview
Table 41. Novartis HER-2 Targeted Drugs for Breast Cancer Products, Services and Solutions
Table 42. Revenue (US$ Million) in HER-2 Targeted Drugs for Breast Cancer Business of Novartis (2016-2021)
Table 43. Novartis Recent Developments
Table 44. Pfizer Basic Information List
Table 45. Pfizer Description and Business Overview
Table 46. Pfizer HER-2 Targeted Drugs for Breast Cancer Products, Services and Solutions
Table 47. Revenue (US$ Million) in HER-2 Targeted Drugs for Breast Cancer Business of Pfizer (2016-2021)
Table 48. Pfizer Recent Developments
Table 49. CANbridge Basic Information List
Table 50. CANbridge Description and Business Overview
Table 51. CANbridge HER-2 Targeted Drugs for Breast Cancer Products, Services and Solutions
Table 52. Revenue (US$ Million) in HER-2 Targeted Drugs for Breast Cancer Business of CANbridge (2016-2021)
Table 53. CANbridge Recent Developments
Table 54. Puma Biotechnology Basic Information List
Table 55. Puma Biotechnology Description and Business Overview
Table 56. Puma Biotechnology HER-2 Targeted Drugs for Breast Cancer Products, Services and Solutions
Table 57. Revenue (US$ Million) in HER-2 Targeted Drugs for Breast Cancer Business of Puma Biotechnology (2016-2021)
Table 58. Puma Biotechnology Recent Developments
Table 59. Hengrui Medicine Basic Information List
Table 60. Hengrui Medicine Description and Business Overview
Table 61. Hengrui Medicine HER-2 Targeted Drugs for Breast Cancer Products, Services and Solutions
Table 62. Revenue (US$ Million) in HER-2 Targeted Drugs for Breast Cancer Business of Hengrui Medicine (2016-2021)
Table 63. Hengrui Medicine Recent Developments
Table 64. Beacon Pharmaceuticals Limited Basic Information List
Table 65. Beacon Pharmaceuticals Limited Description and Business Overview
Table 66. Beacon Pharmaceuticals Limited HER-2 Targeted Drugs for Breast Cancer Products, Services and Solutions
Table 67. Revenue (US$ Million) in HER-2 Targeted Drugs for Breast Cancer Business of Beacon Pharmaceuticals Limited (2016-2021)
Table 68. Beacon Pharmaceuticals Limited Recent Developments
Table 69. Hetero Drugs Basic Information List
Table 70. Hetero Drugs Description and Business Overview
Table 71. Hetero Drugs HER-2 Targeted Drugs for Breast Cancer Products, Services and Solutions
Table 72. Revenue (US$ Million) in HER-2 Targeted Drugs for Breast Cancer Business of Hetero Drugs (2016-2021)
Table 73. Hetero Drugs Recent Developments
Table 74. North America HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 75. North America HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 76. Europe HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 77. Europe HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 78. Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size by Region (2016-2021) & (US$ Million)
Table 79. Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size by Region (2022-2027) & (US$ Million)
Table 80. Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Share by Region (2016-2021)
Table 81. Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Share by Region (2022-2027)
Table 82. Latin America HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 83. Latin America HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 84. Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size by Players (2016-2021) & (US$ Million)
Table 85. Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 86. HER-2 Targeted Drugs for Breast Cancer Market Trends
Table 87. HER-2 Targeted Drugs for Breast Cancer Market Drivers
Table 88. HER-2 Targeted Drugs for Breast Cancer Market Challenges
Table 89. HER-2 Targeted Drugs for Breast Cancer Market Restraints
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
List of Figures
Figure 1. Global HER-2 Targeted Drugs for Breast Cancer Market Size Year-over-Year 2016-2027 & (US$ Million)
Figure 2. Global HER-2 Targeted Drugs for Breast Cancer Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 3. Global HER-2 Targeted Drugs for Breast Cancer Market Share by Regions: 2021 VS 2027
Figure 4. Global HER-2 Targeted Drugs for Breast Cancer Forecasted Market Size Share by Region (2022-2027)
Figure 5. North America HER-2 Targeted Drugs for Breast Cancer Market Size (US$ Million) Growth Rate (2016-2027)
Figure 6. Europe HER-2 Targeted Drugs for Breast Cancer Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 7. Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 8. Latin America HER-2 Targeted Drugs for Breast Cancer Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 9. Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size (US$ Million) and Growth Rate (2016-2027)
Figure 10. Global HER-2 Targeted Drugs for Breast Cancer Market Size Share by Type in 2021 & 2027
Figure 11. Trastuzumab Market Size (US$ Million) YoY Growth (2016-2027)
Figure 12. Pertuzumab Market Size (US$ Million) YoY Growth (2016-2027)
Figure 13. Lapatinib Market Size (US$ Million) YoY Growth (2016-2027)
Figure 14. Neratinib Market Size (US$ Million) YoY Growth (2016-2027)
Figure 15. Trastuzumab Emtansine Market Size (US$ Million) YoY Growth (2016-2027)
Figure 16. Pyrotinib Market Size (US$ Million) YoY Growth (2016-2027)
Figure 17. Global HER-2 Targeted Drugs for Breast Cancer Market Size Share by Application in 2021 & 2027
Figure 18. Hospital Market Size (US$ Million) YoY Growth (2016-2027)
Figure 19. Clinic Market Size (US$ Million) YoY Growth (2016-2027)
Figure 20. Drug Center Market Size (US$ Million) YoY Growth (2016-2027)
Figure 21. Other Market Size (US$ Million) YoY Growth (2016-2027)
Figure 22. HER-2 Targeted Drugs for Breast Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 23. Global Top 5 and Top 10 Players HER-2 Targeted Drugs for Breast Cancer Market Share in 2020
Figure 24. North America HER-2 Targeted Drugs for Breast Cancer Market Share by Country (2016-2027)
Figure 25. United States HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027) & (US$ Million)
Figure 26. Canada HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027) & (US$ Million)
Figure 27. Germany HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027) & (US$ Million)
Figure 28. France HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027) & (US$ Million)
Figure 29. U.K. HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027) & (US$ Million)
Figure 30. Italy HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027) & (US$ Million)
Figure 31. Russia HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027) & (US$ Million)
Figure 32. Nordic HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027) & (US$ Million)
Figure 33. Rest of Europe HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Share by Region (2016-2027)
Figure 35. China HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027) & (US$ Million)
Figure 36. Japan HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027) & (US$ Million)
Figure 37. South Korea HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027) & (US$ Million)
Figure 38. Southeast Asia HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027) & (US$ Million)
Figure 39. India HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027) & (US$ Million)
Figure 40. Australia HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027) & (US$ Million)
Figure 41. Rest of Asia-Pacific HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027) & (US$ Million)
Figure 42. Latin America HER-2 Targeted Drugs for Breast Cancer Market Share by Country (2016-2027)
Figure 43. Mexico HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027) & (US$ Million)
Figure 44. Brazil HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027) & (US$ Million)
Figure 45. Rest of Latin America HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027) & (US$ Million)
Figure 46. Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Share by Country (2016-2027)
Figure 47. Turkey HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027) & (US$ Million)
Figure 48. Saudi Arabia HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027) & (US$ Million)
Figure 49. UAE HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027) & (US$ Million)
Figure 50. Rest of Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size (2016-2027) & (US$ Million)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Keyplayers in Global HER-2 Targeted Drugs for Breast Cancer Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
RocheChugai Pharmaceutical
GlaxoSmithKline
Novartis
Pfizer
CANbridge
Puma Biotechnology
Hengrui Medicine
Beacon Pharmaceuticals Limited
Hetero Drugs